Emerging Diagnostic Technologies: Proving the Clinical Application through Gold Standard Data Webinar
25 Mar 2014 - 25 Mar 2014 - WEBINAR
Tuesday March 25, 2014 - 2:00 PM EST to 3:30 PM EST
With the ability to produce vast amounts of data at an extremely low price, next generation sequencing (NGS) technologies are predicted to become one of the most valuable clinical tools in personalized medicine, and diagnostic manufacturers are exploring a variety of NGS strategies and approaches as uncertainty remains around critical areas such as the extent to which clinicians will adopt these novel technologies, as well as identifying ways to effectively demonstrate their clinical value in the current regulatory and reimbursement environment. The following presentation will provide clinical research professionals with a primer on key considerations in the clinical application of genomic sequencing.
• Pre-development considerations and requirements
• Risk-based review of available technical platforms
• Clarification of the clinical questions: the right sample, gold standard, and reimbursement strategy